TheraB Medical Closes an Oversubscribed Seed Funding Round with Tremendous Support from Investors Across the Country
[May 18, 2024] – TheraB Medical, a leading provider of infant healthcare solutions, is thrilled to announce the oversubscribed closing of their Seed Funding round. This significant milestone is a testament to the unwavering support from their investors, team, and broader community.
"We are incredibly grateful to our incredible investors for their trust and support of our mission," said Alexa Jones, CEO of TheraB Medical. "This investment will enable our continued momentum towards FDA clearance and commercialization of the SnugLit device. We look forward to providing a better care experience to newborns with infant jaundice in 2025."
“We extend our heartfelt gratitude to all the VCs and Angels who followed HEA's lead in the oversubscribed seed funding for TheraB,” said Jack Topdjian, Managing Director at Healthcare Equity Angels. “This support strengthens our conviction that the company is set to revolutionize jaundice treatment, a condition affecting millions of children globally. We eagerly anticipate FDA approval later this year, which will enable us to make this treatment widely accessible to providers and parents, especially in remote and developing regions.”
TheraB Medical extends heartfelt thanks to its entire team, including their advisors and partnering companies, who all play a crucial role as pivotal extensions of the core team pushing the company forward on a daily basis.
This investment round will fuel TheraB Medical’s commercialization of the SnugLit device, the first product in their mission to revolutionize neonatal healthcare.
Suncoast Ventures
Smartgate VC
Baker Bridge Capital
Triple S Ventures
Michigan Rise
Wisconsin River Business Angels
Foster Lane Investments, LLC
Healthcare Equity Angels
Gulf South Angels
For more information about TheraB Medical please visit www.therabmedical.com
-------------------------------------------------
About TheraB Medical:
TheraB Medical is a medical technology company focused on improving neonatal care. The company's flagship product, SnugLit, is a portable and wearable phototherapy device designed for the treatment of infant jaundice. TheraB Medical is dedicated to enhancing the health and well-being of infants and children through innovative medical devices.
Contact:
Alexa Jones, CEO, TheraB Medical
Alexa.jones@therabmedical.com